Depression
From the Journals
PTSD symptoms common in families of COVID-19 patients
Fear may be at the heart of the “psycho-trauma” experienced by family members of COVID-19 patients, said Dr. Elie Azoulay.
From the Journals
Early-onset severe COPD: Similar physical symptoms, but higher depression rates
...
From the Journals
Ketamine fast, effective for suicidal crises
“The effect of ketamine is particularly marked among patients with a bipolar disorder,” said Dr. Fabrice Jollant of the University of Paris.
From the Journals
‘Deaths of despair’ rising, but only in the U.S.
This is not the case in 16 other industrialized nations.
Commentary
Case report: Male with acute new-onset suicidal ideation tied to SARS-CoV-2
We believe our case represents a direct neurocognitive/neuropsychiatric insult due to the COVID-19 infection.
Latest News
HIV stigma persists globally, according to Harris poll
Pervasive stereotypes and stigmatization only serve to magnify preexisting social inequities that affect access to appropriate care.
From the Journals
Psychedelic therapy and suicide: A myth busted?
Effect sizes for reductions in suicidality were “large” at all acute time points, with standardized mean differences (SMD) ranging from -1.48 to -...
From the Journals
Ketamine versus ECT for depression: First head-to-head results
ECT proved more effective than intravenous ketamine in hospitalized patients with severe depression, said Dr. Pouya Movahed Rad.
Latest News
New AAD guidelines eye comorbidities in adults with atopic dermatitis
The guidelines are the first in a four-part series on AD expected to be published over the next 1-2 years.
From the Journals
Ketamine an ‘intriguing new therapy’ for alcoholism
“Ketamine may support alcohol abstinence by temporarily alleviating depressive symptoms during the relapse period.”
Commentary
Identifying and preventing IPV: Are clinicians doing enough?
It is incumbent upon clinicians to learn to quickly identify survivors of intimate partner violence.